共有 50 笔近期内部人交易记录记录，涉及 PTC Therapeutics, Inc. (PTCT), 包括 9 笔买入 和 40 笔卖出. 内部人买入总额为 $13.96M 内部人卖出总额为 $6.06M.
近期活跃的重要内部人包括 Golden Lee Scott, Almstead Neil Gregory, Chutter Jessica Caroline. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — PTCT
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-04-02 |
Golden Lee Scott |
EVP & Chief Medical Officer |
知情卖出 |
829 |
$67.99 |
$56.36K |
79,115 |
| 2026-04-01 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
知情卖出 |
80 |
$70.30 |
$5.62K |
60,137 |
| 2026-03-24 |
Chutter Jessica Caroline |
Officer |
未知 |
- |
- |
- |
- |
| 2026-03-24 |
Chutter Jessica Caroline |
Director |
限制性股票授予 (RSU) |
2,896 |
$64.54 |
$186.91K |
2,896 |
| 2026-03-12 |
Klein Matthew B. |
Chief Executive Officer |
知情卖出 |
2,662 |
$64.08 |
$170.58K |
396,920 |
| 2026-03-11 |
Klein Matthew B. |
Chief Executive Officer |
限制性股票授予 (RSU) |
12,500 |
- |
- |
399,582 |
| 2026-03-10 |
Okey Stephanie |
Director |
期权行权（卖出） |
14,000 |
$33.63 |
$470.82K |
- |
| 2026-03-05 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
知情卖出 |
3,989 |
$63.38 |
$252.82K |
2,737 |
| 2026-03-05 |
Golden Lee Scott |
EVP & Chief Medical Officer |
知情卖出 |
10,000 |
$63.38 |
$633.8K |
79,944 |
| 2026-03-05 |
Okey Stephanie |
Director |
知情卖出 |
6,333 |
$63.38 |
$401.39K |
8,000 |
| 2026-02-19 |
Boulding Mark Elliott |
Exec. VP and CLO |
知情卖出 |
590 |
$69.82 |
$41.19K |
105,212 |
| 2026-02-18 |
Boulding Mark Elliott |
Exec. VP and CLO |
知情卖出 |
3,081 |
$69.36 |
$213.7K |
108,231 |
| 2026-02-18 |
Pauwels Eric |
Chief Business Officer |
知情卖出 |
3,019 |
$69.36 |
$209.4K |
77,122 |
| 2026-02-18 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
知情卖出 |
65 |
$69.36 |
$4.51K |
6,726 |
| 2026-02-18 |
Golden Lee Scott |
EVP & Chief Medical Officer |
知情卖出 |
2,484 |
$69.36 |
$172.29K |
89,944 |
| 2026-02-18 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
知情卖出 |
2,494 |
$69.36 |
$172.98K |
70,199 |
| 2026-02-18 |
Klein Matthew B. |
Chief Executive Officer |
知情卖出 |
7,371 |
$69.36 |
$511.25K |
387,082 |
| 2026-02-18 |
Gravier Pierre |
Chief Financial Officer |
知情卖出 |
2,992 |
$69.36 |
$207.53K |
87,318 |
| 2026-02-17 |
Boulding Mark Elliott |
Exec. VP and CLO |
期权行权（卖出） |
2,813 |
$25.69 |
$72.27K |
22,501 |
| 2026-01-12 |
Pauwels Eric |
Chief Business Officer |
知情卖出 |
1,024 |
$78.70 |
$80.59K |
80,141 |
| 2026-01-09 |
Pauwels Eric |
Chief Business Officer |
知情卖出 |
1,722 |
$77.41 |
$133.3K |
81,165 |
| 2026-01-09 |
Boulding Mark Elliott |
Exec. VP and CLO |
知情卖出 |
107 |
$79.52 |
$8.51K |
111,312 |
| 2026-01-08 |
Pauwels Eric |
Chief Business Officer |
知情卖出 |
1,454 |
$76.45 |
$111.16K |
82,887 |
| 2026-01-08 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
知情卖出 |
59 |
$76.45 |
$4.51K |
6,791 |
| 2026-01-08 |
Boulding Mark Elliott |
Exec. VP and CLO |
知情卖出 |
1,286 |
$76.45 |
$98.31K |
113,626 |
| 2026-01-08 |
Golden Lee Scott |
EVP & Chief Medical Officer |
知情卖出 |
866 |
$76.45 |
$66.21K |
92,428 |
| 2026-01-08 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
知情卖出 |
1,034 |
$76.45 |
$79.05K |
72,693 |
| 2026-01-08 |
Klein Matthew B. |
Chief Executive Officer |
知情卖出 |
2,514 |
$76.45 |
$192.2K |
394,453 |
| 2026-01-07 |
Pauwels Eric |
Chief Business Officer |
知情卖出 |
1,352 |
$77.48 |
$104.75K |
87,489 |
| 2026-01-07 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
知情卖出 |
52 |
$77.48 |
$4.03K |
6,850 |
| 2026-01-07 |
Boulding Mark Elliott |
Exec. VP and CLO |
期权行权（卖出） |
751 |
$38.10 |
$28.61K |
- |
| 2026-01-07 |
Golden Lee Scott |
EVP & Chief Medical Officer |
知情卖出 |
642 |
$77.48 |
$49.74K |
93,294 |
| 2026-01-07 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
知情卖出 |
1,235 |
$77.45 |
$95.65K |
73,727 |
| 2026-01-07 |
Klein Matthew B. |
Chief Executive Officer |
知情卖出 |
3,016 |
$77.48 |
$233.68K |
396,967 |
| 2026-01-06 |
Pauwels Eric |
Chief Business Officer |
知情卖出 |
1,789 |
$76.95 |
$137.66K |
88,841 |
| 2026-01-06 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
知情卖出 |
54 |
$76.95 |
$4.16K |
6,902 |
| 2026-01-06 |
Boulding Mark Elliott |
Exec. VP and CLO |
知情卖出 |
1,739 |
$76.95 |
$133.82K |
119,162 |
| 2026-01-06 |
Golden Lee Scott |
EVP & Chief Medical Officer |
知情卖出 |
1,340 |
$76.95 |
$103.11K |
93,936 |
| 2026-01-06 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
知情卖出 |
1,381 |
$76.95 |
$106.27K |
74,962 |
| 2026-01-06 |
Klein Matthew B. |
Chief Executive Officer |
知情卖出 |
5,149 |
$76.95 |
$396.22K |
399,983 |
| 2026-01-06 |
Gravier Pierre |
Chief Financial Officer |
知情卖出 |
2,139 |
$76.95 |
$164.6K |
90,310 |
| 2026-01-05 |
Boulding Mark Elliott |
Exec. VP and CLO |
期权行权（卖出） |
2,266 |
$39.42 |
$89.33K |
9,063 |
| 2026-01-05 |
Reeve Emma |
Director |
期权行权（卖出） |
734 |
$46.54 |
$34.16K |
- |
| 2026-01-02 |
Pauwels Eric |
Chief Business Officer |
限制性股票授予 (RSU) |
50,000 |
$76.74 |
$3.84M |
50,000 |
| 2026-01-02 |
Zeldis Jerome B |
Director |
限制性股票授予 (RSU) |
3,475 |
$76.74 |
$266.67K |
3,475 |
| 2026-01-02 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
限制性股票授予 (RSU) |
520 |
- |
- |
6,956 |
| 2026-01-02 |
Boulding Mark Elliott |
Exec. VP and CLO |
限制性股票授予 (RSU) |
42,500 |
$76.74 |
$3.26M |
42,500 |
| 2026-01-02 |
Reeve Emma |
Director |
限制性股票授予 (RSU) |
3,475 |
$76.74 |
$266.67K |
3,475 |
| 2026-01-02 |
Golden Lee Scott |
EVP & Chief Medical Officer |
限制性股票授予 (RSU) |
46,875 |
$76.74 |
$3.6M |
46,875 |
| 2026-01-02 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
限制性股票授予 (RSU) |
33,125 |
$76.74 |
$2.54M |
33,125 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
